Affymetrix and Athletigen Partner to Advance Genetics in Human Athletic Performance
October 27 2015 - 6:30AM
Business Wire
Affymetrix Inc. (NASDAQ: AFFX) and Athletigen Technologies Inc.,
a direct-to-consumer sports genetics company, today announced a
global partnership agreement. Under the agreement, Athletigen will
use Affymetrix Axiom® genotyping platform for its sports-related
DNA analysis service.
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20151027005521/en/
DNA from a saliva sample will be genotyped using Athletigen’s
DNA microarray which analyzes about 850,000 variants implicated in
human athletic performance. The high quality data generated when
analyzed with Athletigen’s interpretative bioinformatics algorithm
enables the delivery of an online, easy-to-use, actionable report
on traits relating to athleticism, nutrition, and sports
psychology.
“Affymetrix’ Axiom platform offers the gold standard for
genotyping analysis and, when coupled with our highly curated
content selection and interpretative analysis, ensures precision
and accuracy for our personalized sports genetics reports to create
a blueprint for improving human athletic performance,” said Jeremy
Koenig, PhD, CEO of Athletigen Technologies Inc.
“We are pleased to support Athletigen’s sports genetic offering
that empowers athletes and coaches to better understand their
athletic traits. Our high fidelity Axiom genotyping platform, due
to its high throughput capability, industry-leading genotyping
performance, and affordability, is preferred by many large scale
biobank projects worldwide and by emerging consumer genomics
enterprises for genetic analysis of consumer bio-specimens,” said
Laurent Bellon, senior vice president and general manager of the
Genotyping Business Unit of Affymetrix.
About Athletigen
Athletigen Technologies Inc. is transforming the future for how
athletes train. The company provides highly-accurate, sports DNA
analysis direct-to-consumers through an easy-to-use, actionable
dashboard. Athletigen’s sports genetics analysis platform is used
by athletes, trainers, coaches, and health professionals to create
a personalized blueprint for precision performance. The
algorithm-powered platform identifies how your genetics affects
athleticism, nutrition, and sports psychology. Athletigen’s
platform is built on an extensive database of genetic indicators
and peer-reviewed research. To learn more visit
www.athletigen.com.
About Affymetrix
Affymetrix technologies enable multiplex and simultaneous
analysis of biological systems at the cell, protein, and gene
level, facilitating the rapid translation of benchtop research into
clinical and routine use for human health and wellness. Affymetrix
provides leadership and support, partnering with customers in
pharmaceutical, diagnostic, and biotechnology companies as well as
leading academic, government, and non-profit research institutes in
their quest to use biology for a better world. More than 2,300
microarray systems have been shipped around the world and more than
94,000 peer-reviewed papers have been published citing Affymetrix
technologies. Affymetrix is headquartered in Santa Clara,
California, and has manufacturing facilities in Cleveland, San
Diego, Vienna and Singapore. Affymetrix has about 1,100 employees
and maintains sales and distribution operations worldwide. For more
information about Affymetrix, please visit www.affymetrix.com.
Forward-looking statements
All statements in this press release that are not historical are
"forward-looking statements" within the meaning of Section 21E of
the Securities Exchange Act as amended, including statements
regarding Affymetrix' "expectations," "beliefs," "hopes,"
"intentions," "strategies," or the like. Such statements are
subject to risks and uncertainties that could cause actual results
to differ materially for Affymetrix from those projected. These and
other risk factors are discussed in Affymetrix' Form 10-K for the
year ended December 31, 2014, and other SEC reports for subsequent
quarterly periods.
PLEASE NOTE: Affymetrix, the Affymetrix logo, and Axiom
trademarks are the property of Affymetrix, Inc. All other
trademarks are the property of their respective owners.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151027005521/en/
AffymetrixMedia
Contact:Mindy Lee-Olsen, 408-731-5523Vice President,
Marketing Servicesmindy_lee-olsen@affymetrix.comorInvestor Contact:Doug Farrell, 408-731-5285Vice
President, Investor
Relationsdoug_farrell@affymetrix.comorAthletigenMedia Contact:Ashlyn Bernier, PhD, MBA,
780-904-1923Operations Managerashlyn.bernier@athletigen.com
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Sep 2024 to Oct 2024
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Oct 2023 to Oct 2024